Chemistry: analytical and immunological testing – Including chromatography
Reexamination Certificate
2008-12-31
2011-11-22
Menon, Krishnan S (Department: 1777)
Chemistry: analytical and immunological testing
Including chromatography
C436S527000, C436S805000, C422S082050, C422S082090
Reexamination Certificate
active
08062899
ABSTRACT:
An improved chromatographic method for the separation, identification and quantification of contaminants associated with Eosinophelia-Myalgia Syndrome (EMS) includes a high pressure liquid chromatography (HPLC) method which utilizes a silica-based column and a gradient mobile phase. The method provides for effective, efficient, and economical quantitative and qualitative identification of 1,1′-Ethylidenebis L-tryptophan (EBT), 2,3-indolymethyl L-tryptophan (Peak 200), and 2-anilino-L-alanine (Peak 1).
REFERENCES:
patent: 5993653 (1999-11-01), Ahmed et al.
Phenomenex Gemini Two-In-One-Technology (Twin Technology), 2004.
Zhao et al., 1999, Carcinogenesis, vol. 20, No. 11, pp. 2101-2108.
Hill, Robert H., Jr. et al., “Contaminants in L-Tryptophan Associated with Eosinophelia Myalgia Syndrome,” Arch. Environ. Contam. Toxicol. 25,134-142 (1993).
Williamson, B.L., et al., “On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of eosinophelia-myalgia syndrome,” Toxicology Letters, 92(2), 139-148 (1997)—Abstract only.
ESA Note 5600A, “Tryptophan Contamination,” ESA, Inc.
Trucksess, MW, et al., “High-performance liquid chromatographic determination of 1,1′-ethylidenebis(L-tryptophan) in L-tryptophan preparations,” J. Pharm. Sci., 83(5), 720-722 (May 1994)—Abstract only.
Zangrilli, JG, et al., “1,1′-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophelia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro,” Biochem. Mol. Biol. Int., 37(5), 925-933 (Nov. 1995)—Abstract only.
Trucksess, MW, “Separation and isolation of trace impurities in L-tryptophan by high-performance liquid chromatography,” J. Chromatogr., 630(1-2), 147-150 (Feb. 5, 1993)—Abstract only.
Smith, M.J., et al., “1,1′-Ethylidenebis(l-tryptophan), Structure Determination of Contaminant “97”—Implicated in the Eosinophelia-Myalgia Syndrome (EMS),” Tetrahedron Letters, 32(8), 991-994 (1991).
Love, L. A., et al., “Pathological and Immunological Effects of Ingesting L-Tryptophan and 1,1′-Ethylidenebis(L-Tryptophan) in Lewis Rats,” J. Clinical Invest., 91, 804-811 (Mar. 1993).
Amin Tatati, LLC
Carrera, Jr. George M.
Gionta Allison M
Menon Krishnan S
Moderson Janine A.
LandOfFree
Identification and quantitative determination of major... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Identification and quantitative determination of major..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Identification and quantitative determination of major... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4311244